Skip to main content
. 2023 May 28;9(5):354–366. doi: 10.1002/cjp2.326

Table 4.

Univariate analysis (OS).

Factor Median OS (date) P value
Age (years): <65 versus ≧65 943 versus 979 0.528
Male versus female 711 versus 1,166 0.111
Location: body‐tail versus head 1,166 versus 943 0.52
Tumor size (mm): <30 versus ≧30 1,010 versus 711 <0.05
T1–2 versus T3–4 979 versus 847 0.216
N: N0 versus N1 1,184 versus 646 <0.05
CA19‐9 (U/ml): <200 versus ≧200 1,097 versus 602 <0.01
Adjuvant chemotherapy: (−) versus (+) 537 versus 1,163 <0.01
HbA1c (%): <6.5 versus ≧6.5 1,166 versus 742 <0.05
DM: (−) versus (+) 1,184 versus 847 0.074
Long‐DM: (−) versus (+) 1,066 versus 632 <0.05
miR‐100‐5p expression: <4.13 versus ≧4.13 1,184 versus 703 <0.05
CDH1 promoter methylation: (−) versus (+) 1,001 versus 602 <0.01